ATE316375T1 - Orale feste zusammensetzung - Google Patents

Orale feste zusammensetzung

Info

Publication number
ATE316375T1
ATE316375T1 AT00974881T AT00974881T ATE316375T1 AT E316375 T1 ATE316375 T1 AT E316375T1 AT 00974881 T AT00974881 T AT 00974881T AT 00974881 T AT00974881 T AT 00974881T AT E316375 T1 ATE316375 T1 AT E316375T1
Authority
AT
Austria
Prior art keywords
pharmaceutical
krp
quantitatively
oral solid
additives
Prior art date
Application number
AT00974881T
Other languages
English (en)
Inventor
Toshinori Ohyama
Masahiko Ohishi
Yasuhiro Yamamoto
Original Assignee
Kyorin Seiyaku Kk
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Kyorin Seiyaku Kk filed Critical Kyorin Seiyaku Kk
Application granted granted Critical
Publication of ATE316375T1 publication Critical patent/ATE316375T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4164—1,3-Diazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806—Coating materials
    • A61K9/2813—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806—Coating materials
    • A61K9/2833—Organic macromolecular compounds
    • A61K9/284—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806—Coating materials
    • A61K9/2833—Organic macromolecular compounds
    • A61K9/286—Polysaccharides, e.g. gums; Cyclodextrin
    • A61K9/2866—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Inorganic Chemistry (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Urology & Nephrology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
AT00974881T 1999-11-11 2000-11-10 Orale feste zusammensetzung ATE316375T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP32058599 1999-11-11

Publications (1)

Publication Number Publication Date
ATE316375T1 true ATE316375T1 (de) 2006-02-15

Family

ID=18123071

Family Applications (1)

Application Number Title Priority Date Filing Date
AT00974881T ATE316375T1 (de) 1999-11-11 2000-11-10 Orale feste zusammensetzung

Country Status (12)

Country Link
US (1) US7351429B1 (de)
EP (1) EP1245232B1 (de)
JP (1) JP4610834B2 (de)
AT (1) ATE316375T1 (de)
AU (1) AU1304501A (de)
CA (1) CA2390933C (de)
CY (1) CY1104982T1 (de)
DE (1) DE60025750T2 (de)
DK (1) DK1245232T3 (de)
ES (1) ES2254246T3 (de)
TW (1) TWI221412B (de)
WO (1) WO2001034147A1 (de)

Families Citing this family (35)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP5548329B2 (ja) * 2003-08-04 2014-07-16 杏林製薬株式会社 経皮吸収型製剤
CA2532714C (en) * 2003-08-04 2010-11-16 Kyorin Pharmaceutical Co., Ltd. Oral sustained-release tablet comprising 4-(2-methyl-1-imidazolyl)-2,2-diphenylbutylamide
AU2004290520A1 (en) * 2003-11-18 2005-06-02 Boehringer Ingelheim International Gmbh Solid pharmaceutical preparation form
KR20070115918A (ko) * 2005-01-31 2007-12-06 교린 세이야꾸 가부시키 가이샤 멀티플 유닛형 경구 서방성 제제 및 그 제조방법
WO2006082888A1 (ja) 2005-02-03 2006-08-10 Kyorin Pharmaceutical Co., Ltd. 経皮吸収型製剤
KR101528954B1 (ko) * 2008-01-31 2015-06-15 교린 세이야꾸 가부시키 가이샤 이미다페나신 함유 구강 내 속붕괴성 정제
DK2246051T3 (da) 2008-01-31 2014-01-13 Kyorin Seiyaku Kk Fremgangsmåde til fremstilling af oralt sig hurtigt opløsende tablet omfattende imidafenacin som aktiv bestanddel
JP5452051B2 (ja) * 2009-03-27 2014-03-26 杏林製薬株式会社 イミダフェナシン含有口腔内崩壊錠
JP5452050B2 (ja) * 2009-03-27 2014-03-26 杏林製薬株式会社 イミダフェナシンを含有する口腔内崩壊錠
JP5713544B2 (ja) * 2009-07-30 2015-05-07 杏林製薬株式会社 イミダフェナシン含有口腔内速崩錠
JP5844573B2 (ja) * 2011-08-10 2016-01-20 共和薬品工業株式会社 ピタバスタチンを含有する錠剤
JP5757493B1 (ja) * 2014-09-24 2015-07-29 富田製薬株式会社 経口型鉄分補給用固形組成物及びその製造方法
JP6127295B2 (ja) * 2015-03-10 2017-05-17 杏林製薬株式会社 イミダフェナシン含有口腔内速崩錠
BR112017019918B1 (pt) 2015-03-19 2023-11-07 Daiichi Sankyo Company, Limited Preparação sólida farmacêutica, e, método para produzir uma preparação sólida farmacêutica para estabilizar uma preparação sólida farmacêutica
BR112017019920B1 (pt) * 2015-03-19 2023-11-07 Daiichi Sankyo Company, Limited Preparação sólida farmacêutica, e, método para estabilização de uma preparação sólida farmacêutica
JP6072884B2 (ja) * 2015-11-19 2017-02-01 共和薬品工業株式会社 ピタバスタチンを含有する製剤
US10517851B2 (en) 2015-12-25 2019-12-31 Kyorin Pharmaceutical Co., Ltd. Vasopressin-like action enhancer
JP6212588B2 (ja) * 2016-03-24 2017-10-11 杏林製薬株式会社 イミダフェナシン含有口腔内速崩錠
US11065207B2 (en) * 2016-03-25 2021-07-20 Universiteit Gent Oral dosage form
US10966928B2 (en) * 2016-03-25 2021-04-06 Universiteit Gent Oral dosage form
JP6303038B2 (ja) * 2017-02-14 2018-03-28 杏林製薬株式会社 イミダフェナシン含有口腔内速崩錠
JP6303037B2 (ja) * 2017-02-14 2018-03-28 杏林製薬株式会社 イミダフェナシン含有口腔内速崩錠
JP6435363B2 (ja) * 2017-03-30 2018-12-05 杏林製薬株式会社 湿式造粒法によるイミダフェナシンを含有する造粒物の製造方法
JP6423034B2 (ja) * 2017-03-30 2018-11-14 杏林製薬株式会社 イミダフェナシン含有錠剤
JP6423035B2 (ja) * 2017-03-30 2018-11-14 杏林製薬株式会社 イミダフェナシン含有造粒物のコーティング顆粒
JP6435362B2 (ja) * 2017-03-30 2018-12-05 杏林製薬株式会社 保存安定性に優れたイミダフェナシンを含有する製剤
JP6509934B2 (ja) * 2017-03-30 2019-05-08 杏林製薬株式会社 直打法によるイミダフェナシンを含有する錠剤の製造方法
JP6423033B2 (ja) * 2017-03-30 2018-11-14 杏林製薬株式会社 製造工程分解物の少ないイミダフェナシンを含有する造粒物
JP6303045B1 (ja) * 2017-03-30 2018-03-28 杏林製薬株式会社 攪拌造粒法を用いたイミダフェナシンを含有する製剤の製造方法
JP6303044B1 (ja) * 2017-03-30 2018-03-28 杏林製薬株式会社 押出し造粒法を用いたイミダフェナシンを含有する製剤の製造方法
JP7365157B2 (ja) * 2018-07-17 2023-10-19 沢井製薬株式会社 イミダフェナシン含有錠剤の製造方法
BR112021001008A2 (pt) 2018-07-30 2021-04-20 Daiichi Sankyo Company, Limited comprimido de fármaco
JP2018203789A (ja) * 2018-10-09 2018-12-27 杏林製薬株式会社 製造工程分解物の少ないイミダフェナシンを含有する造粒物
JP2019019148A (ja) * 2018-11-12 2019-02-07 杏林製薬株式会社 保存安定性に優れたイミダフェナシンを含有する製剤
JP2019104761A (ja) * 2019-04-03 2019-06-27 杏林製薬株式会社 直打法によるイミダフェナシンを含有する錠剤の製造方法

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS58206533A (ja) 1982-05-27 1983-12-01 Teijin Ltd 活性型ビタミンｄ↓３誘導体組成物及びそれを活性成分とする薬剤
US4797405A (en) * 1987-10-26 1989-01-10 Eli Lilly And Company Stabilized pergolide compositions
US5084278A (en) * 1989-06-02 1992-01-28 Nortec Development Associates, Inc. Taste-masked pharmaceutical compositions
JP3294961B2 (ja) 1993-12-10 2002-06-24 杏林製薬株式会社 新規イミダゾール誘導体及びその製造法
US5948437A (en) * 1996-05-23 1999-09-07 Zeneca Limited Pharmaceutical compositions using thiazepine
ATE241341T1 (de) 1997-09-10 2003-06-15 Takeda Chemical Industries Ltd Stabilisierte pharmazeutische zusammensetzung
JP4730985B2 (ja) * 1997-09-10 2011-07-20 武田薬品工業株式会社 安定化された医薬製剤
JP3901832B2 (ja) * 1998-03-13 2007-04-04 大日本インキ化学工業株式会社 キノリノン誘導体製剤、及びその製造法

Also Published As

Publication number Publication date
AU1304501A (en) 2001-06-06
DK1245232T3 (da) 2006-03-06
WO2001034147A1 (en) 2001-05-17
JP4610834B2 (ja) 2011-01-12
EP1245232A4 (de) 2004-05-06
EP1245232B1 (de) 2006-01-25
US7351429B1 (en) 2008-04-01
DE60025750T2 (de) 2006-10-19
CA2390933C (en) 2009-07-14
EP1245232A1 (de) 2002-10-02
ES2254246T3 (es) 2006-06-16
TWI221412B (en) 2004-10-01
CY1104982T1 (el) 2009-11-04
DE60025750D1 (de) 2006-04-13
CA2390933A1 (en) 2001-05-17

Similar Documents

Publication Publication Date Title
ATE316375T1 (de) Orale feste zusammensetzung
NO2013002I2 (no) Aklidiniumsalt med et farmaøytisk akseptabelt anion av en mono-eller polyvalent syre, spesielt aklidiniumbromid
DE69206345D1 (de) Arzneimittel zur intranasalen Verabreichung, die Ketorolac R enthalten.
NO2002009I2 (no) Tiotropium
SE9402431D0 (sv) New tablet formulation
DK1205190T3 (da) Stabile medicinalsammensætninger til oral administration og med anvendelse af ferrioxider
SE9902386D0 (sv) New formulation
GR3005818T3 (de)
DE3686483D1 (de) Arzneimittel.
MY129473A (en) 3,3-diarylpropylamines, their use and preparation
ATE87481T1 (de) Orale arzneimittelformen von pimobendan.
NZ514248A (en) Pharmaceutical composition in a unit form containing acetylsalcylic acid and clopidogrel hydrogenosulphate
UA35604C2 (uk) Фармацевтична композиція з антидепресивною активністю
DE69228674D1 (de) Nichtsteroide-entzündungshemmende Arzneimittel und Decongestirum enthaltende Augenarzneimittelzusammensetzung
DE60123100D1 (de) Honig enthaltende pharmazeutische zusammensetzung zur wundbehandlung
GB9814215D0 (en) Anti-inflammatory pharmaceutical formulations
ATE38151T1 (de) Bestaendige 5-adenosyl-l-methionin-salze enthaltende, pharmazeutische zusammensetzungen fuer orale anwendung.
ES2124861T3 (es) Derivados de aminoacidos y su utilizacion como inhibidores de la encefalinasa.
DE69929635D1 (de) Neue pharmazeutische zusammenstellung und deren herstellungsprozess
MY100483A (en) Niflumic acid morpholinoethyl ester diniflumate, preparation, use in therapeutics as analgesic and anti- inflammatory
DK0615439T3 (da) Iburprofenholdigt retard-lægemiddel og dets anvendelse
DK0615447T3 (da) Flurbiprofen-holdigt retard-lægemiddel og dets anvendelse
ES456094A1 (es) Un procedimiento para la preparacion de 2-acetoxi-benzoato de 2-(carbamoil) fenilo.
IE811773L (en) Pharmaceutical comosition containing imidazolesalicylate
GB950065A (en) Pharmaceutical preparations comprising 1:3-benzoxazine-2:4-dione

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1245232

Country of ref document: EP